Previous studies determining the serum levels of MMP-9 in patients with head and neck SCC (HNSCC) have shown that these individuals present higher levels compared to the control group, both preoperatively and postoperatively, without a correlation with the histological type or clinical characteristics of the tumor [31,32]. The gene discussed is MMP9; the disease is neoplasm.